Thase M E
Western Psychiatric Institute and Clinic, University of Pittsburgh, Pennsylvania, USA.
J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):10S-18S; discussion 18S-20S. doi: 10.1097/00004714-199606002-00003.
Depression is often related to disturbances of norepinephrine and serotonin neurochemical systems within the brain that affect functional neurobehavioral systems. Classes of antidepressant agents have been developed that directly affect proposed brain neurochemical alterations. Many of the differences among antidepressant agents, particularly in safety and tolerability, can be attributed to their differing effects on receptor blockade and neurotransmitter reuptake. The overall goal of antidepressant treatment is complete recovery, and three phases of treatment have been delineated. Because of the recurrent and potentially chronic nature of depression, safety and tolerability of available treatments are especially important. An overview of antidepressant options is presented, with a particular focus on venlafaxine.
抑郁症常与大脑中去甲肾上腺素和血清素神经化学系统的紊乱有关,这些紊乱会影响功能性神经行为系统。已经开发出了直接影响大脑神经化学改变的抗抑郁药类别。抗抑郁药之间的许多差异,尤其是在安全性和耐受性方面,可归因于它们对受体阻断和神经递质再摄取的不同作用。抗抑郁治疗的总体目标是完全康复,并且已经划分出三个治疗阶段。由于抑郁症具有复发性和潜在的慢性特点,现有治疗方法的安全性和耐受性尤为重要。本文将概述抗抑郁药的选择,特别关注文拉法辛。